Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research
The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…
IIL launches virtual medical representatives
eMOz will eventually be acquiring AI avatars of sales representatives to interact and assist physicians in one of its kind…
NATCO announces ANDA filing for generic olaparib tablets in US
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer
Sun Pharma recalls 34000 bottles of Diltiazem Hydrochloride extended-release capsules from US
The capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats failed dissolution testing
The (pharma) sector is learning to create capabilities in innovative R&D rapidly
Dr Sanjay Kumar Jain, President - India Operations, Amneal Pharmaceuticals speaks about the emerging trends in pharma R&D,…
LPC 150 Conclave to be held at NIPER Hyderabad on March 12, 2023
The theme of the event is Pharma 4.0: Digital transformation across pharmaceuticals
Covid vaccines do not increase risk of adverse events: Study
The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous…
Express Pharma-Nutrify Today Boardroom series to be launched this February
The Express Pharma- Nutrify Today Boardroom series, to be held in various cities of India through 2023, is an endeavour to…
AI facilitates low-cost drug repurposing: GlobalData
AI is advancing drug repurposing by mining huge biomedical datasets for hidden patterns and evidence
Sun Pharma gets US FDA nod for generic lenalidomide capsules
The respective product approval is based on Revlimid Capsules, 5 mg, 10 mg, 15 mg, 25 mg and 2.5 mg, 20 mg as a reference product